Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

P. Boddu; J. Jorgensen; H. Kantarjian; G. Borthakur; T. Kadia; N. Daver; Y. Alvarado; N. Pemmaraju; P. Bose; K. Naqvi; M. Yilmaz; S. Pierce; M. Brandt; C. D. DiNardo; E. J. Jabbour; M. Konopleva; G. Garcia-Manero; J. Cortes; F. Ravandi

doi:10.1038/leu.2017.285

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

P. Boddu, J. Jorgensen, H. Kantarjian, G. Borthakur, T. Kadia, N. Daver, Y. Alvarado, N. Pemmaraju, P. Bose, K. Naqvi, M. Yilmaz, S. Pierce, M. Brandt, C. D. DiNardo, E. J. Jabbour, M. Konopleva, G. Garcia-Manero, J. Cortes, F. Ravandi

Research output: Contribution to journal › Letter › peer-review

42 Scopus citations

Original language	English (US)
Pages (from-to)	241-244
Number of pages	4
Journal	Leukemia
Volume	32
Issue number	1
DOIs	https://doi.org/10.1038/leu.2017.285
State	Published - Jan 2018
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2017.285

Cite this

Boddu, P., Jorgensen, J., Kantarjian, H., Borthakur, G., Kadia, T., Daver, N., Alvarado, Y., Pemmaraju, N., Bose, P., Naqvi, K., Yilmaz, M., Pierce, S., Brandt, M., DiNardo, C. D., Jabbour, E. J., Konopleva, M., Garcia-Manero, G., Cortes, J., & Ravandi, F. (2018). Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse. Leukemia, 32(1), 241-244. https://doi.org/10.1038/leu.2017.285

Boddu, P, Jorgensen, J, Kantarjian, H, Borthakur, G, Kadia, T, Daver, N, Alvarado, Y, Pemmaraju, N, Bose, P, Naqvi, K, Yilmaz, M, Pierce, S, Brandt, M, DiNardo, CD, Jabbour, EJ, Konopleva, M, Garcia-Manero, G, Cortes, J & Ravandi, F 2018, 'Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse', Leukemia, vol. 32, no. 1, pp. 241-244. https://doi.org/10.1038/leu.2017.285

@article{955876f7b7be4ae88c82c44f21c9d397,

title = "Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse",

author = "P. Boddu and J. Jorgensen and H. Kantarjian and G. Borthakur and T. Kadia and N. Daver and Y. Alvarado and N. Pemmaraju and P. Bose and K. Naqvi and M. Yilmaz and S. Pierce and M. Brandt and DiNardo, {C. D.} and Jabbour, {E. J.} and M. Konopleva and G. Garcia-Manero and J. Cortes and F. Ravandi",

note = "Funding Information: We thank Mary Akosile and Graciela M Nogueras Gonzalez for providing valuable statistical input in the construction of data and performing statistical analysis. This study was supported by University of Texas MD Anderson Cancer Center Support Grant (P30 CA16672) and by the Leukemia SPORE Grant (P50 CA100632).",

year = "2018",

month = jan,

doi = "10.1038/leu.2017.285",

language = "English (US)",

volume = "32",

pages = "241--244",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

AU - Boddu, P.

AU - Jorgensen, J.

AU - Kantarjian, H.

AU - Borthakur, G.

AU - Kadia, T.

AU - Daver, N.

AU - Alvarado, Y.

AU - Pemmaraju, N.

AU - Bose, P.

AU - Naqvi, K.

AU - Yilmaz, M.

AU - Pierce, S.

AU - Brandt, M.

AU - DiNardo, C. D.

AU - Jabbour, E. J.

AU - Konopleva, M.

AU - Garcia-Manero, G.

AU - Cortes, J.

AU - Ravandi, F.

N1 - Funding Information: We thank Mary Akosile and Graciela M Nogueras Gonzalez for providing valuable statistical input in the construction of data and performing statistical analysis. This study was supported by University of Texas MD Anderson Cancer Center Support Grant (P30 CA16672) and by the Leukemia SPORE Grant (P50 CA100632).

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85048469251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048469251&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.285

DO - 10.1038/leu.2017.285

M3 - Letter

C2 - 28919634

AN - SCOPUS:85048469251

SN - 0887-6924

VL - 32

SP - 241

EP - 244

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this